News

Becker's Hospital Review28d
FDA approves Dupixent as first chronic spontaneous urticaria therapy in over a decade
The condition is linked to Type 2 inflammation, which Dupixent helps target by blocking certain immune signaling pathways. The injection is already approved for CSU in several other countries ...
PharmiWeb25d
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
Dupixent (dupilumab) is an injection administered under the skin (subcutaneous ... guidance of a healthcare professional and can be given in a clinic or at home after training by a healthcare ...
Hosted on MSN19d
Dupixent: The First FDA-Approved Biologic Drug to Treat Uncontrolled COPD
The list price is $3,993 for a one-month supply. Dupixent is administered as an injection under the skin every two weeks. Fawzy said that in his experience prescribing Dupixent for asthma ...
Morningstar1mon
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Dupixent is an injection administered under the skin ... professional and can be given in a clinic or at home after training by a healthcare professional. In adolescents aged 12 to 17 years ...